News Medical on MSN18d
Key reason why some cancers do not respond to immunotherapy identified
Research reveals SLC13A3's role in tumor cell survival and immune therapy resistance, highlighting its potential as a target ...
News Medical on MSN16d
CAR T cell therapy breakthroughs bring new hope for treating solid tumors
Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...
POSTECH team pioneers new cancer therapy strategy: targeting GLUT3 in regulatory T cells to supercharge anti-tumor immunity
TIL-Tregs specifically increase GLUT3 expression for glucose uptake in tumors. - GLUT3 fuels protein O-GlcNAcylation, ...
Discovery of new mechanism explains how ovarian cancer disables immune cells
A significant obstacle in treating ovarian cancer is the tumor microenvironment—the complex ... the researchers discovered ...
GEN1mon
Eczema Drugs Could Counter Ovarian Cancer’s IL-4-Based Immunotherapy Resistance
“The ovarian tumor microenvironment (TME) is commonly in an immune-suppressed state with local exclusion and/or suppression of T cells, which is considered a contributing factor to the poor ICB ...
Science Daily1mon
Novel role of BRCA1 in tumor suppression
Research shows that the breast cancer gene 1 (BRCA1) not only pushes accurate DNA repair to guard against cancer but promotes subsequent activity in tumor suppression. A new study led by The ...